Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-294207
Filing Date
2011-11-03
Accepted
2011-11-03 09:26:39
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d231460d10q.htm 10-Q 483333
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 d231460dex311.htm EX-31.1 9717
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 d231460dex312.htm EX-31.2 9718
4 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 d231460dex321.htm EX-32.1 5062
  Complete submission text file 0001193125-11-294207.txt   1697831

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ptie-20110930.xml EX-101.INS 233917
6 XBRL TAXONOMY EXTENSION SCHEMA ptie-20110930.xsd EX-101.SCH 8959
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptie-20110930_cal.xml EX-101.CAL 27175
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptie-20110930_lab.xml EX-101.LAB 92141
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptie-20110930_pre.xml EX-101.PRE 58070
Mailing Address 2211 BRIDGEPOINTE PARKWAY SUITE 500 SAN MATEO CA 94404
Business Address 2211 BRIDGEPOINTE PARKWAY SUITE 500 SAN MATEO CA 94404 6506248200
PAIN THERAPEUTICS INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29959 | Film No.: 111176287
SIC: 2834 Pharmaceutical Preparations